Terms: = Lymphoma AND IKZF1, LyF-1, 10320, ENSG00000185811, Q13422, Hs_54452, hIk-1, ZNFN1A1, IKAROS
501 results:
1. Shared genetic architecture between autoimmune disorders and B-cell acute lymphoblastic leukemia: insights from large-scale genome-wide cross-trait analysis.
Yu X; Chen Y; Chen J; Fan Y; Lu H; Wu D; Xu Y
BMC Med; 2024 Apr; 22(1):161. PubMed ID: 38616254
[TBL] [Abstract] [Full Text] [Related]
2. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
[TBL] [Abstract] [Full Text] [Related]
3. A noncoding regulatory variant in ikzf1 increases acute lymphoblastic leukemia risk in Hispanic/Latino children.
de Smith AJ; Wahlster L; Jeon S; Kachuri L; Black S; Langie J; Cato LD; Nakatsuka N; Chan TF; Xia G; Mazumder S; Yang W; Gazal S; Eng C; Hu D; Burchard EG; Ziv E; Metayer C; Mancuso N; Yang JJ; Ma X; Wiemels JL; Yu F; Chiang CWK; Sankaran VG
Cell Genom; 2024 Apr; 4(4):100526. PubMed ID: 38537633
[TBL] [Abstract] [Full Text] [Related]
4. STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.
Prutsch N; He S; Berezovskaya A; Durbin AD; Dharia NV; Maher KA; Matthews JD; Hare L; Turner SD; Stegmaier K; Kenner L; Merkel O; Look AT; Abraham BJ; Zimmerman MW
Cell Rep Med; 2024 Mar; 5(3):101472. PubMed ID: 38508140
[TBL] [Abstract] [Full Text] [Related]
5. Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: Combining ikzf1
Liu HC; Huang YJ; Jaing TH; Wu KH; Chen SH; Wang SC; Yeh TC; Hsiao CC; Chang TK; Yen HJ; Huang FL; Lin PC; Hou JY; Sheen JM; Liao YM; Chang TY; Chen YC; Chiou SS; Yang CP; Pui CH; Liang DC; Shih LY
Br J Haematol; 2024 Apr; 204(4):1344-1353. PubMed ID: 38479427
[TBL] [Abstract] [Full Text] [Related]
6. Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
van Outersterp I; Boer JM; van de Ven C; Reichert CEJ; Boeree A; Kruisinga B; de Groot-Kruseman HA; Escherich G; Sijs-Szabo A; Rijneveld AW; den Boer ML
Blood Adv; 2024 Apr; 8(8):1835-1845. PubMed ID: 38386975
[TBL] [Abstract] [Full Text] [Related]
7. Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and ikzf1/3 degrader NX-2127.
Montoya S; Bourcier J; Noviski M; Lu H; Thompson MC; Chirino A; Jahn J; Sondhi AK; Gajewski S; Tan YSM; Yung S; Urban A; Wang E; Han C; Mi X; Kim WJ; Sievers Q; Auger P; Bousquet H; Brathaban N; Bravo B; Gessner M; Guiducci C; Iuliano JN; Kane T; Mukerji R; Reddy PJ; Powers J; Sanchez Garcia de Los Rios M; Ye J; Barrientos Risso C; Tsai D; Pardo G; Notti RQ; Pardo A; Affer M; Nawaratne V; Totiger TM; Pena-Velasquez C; Rhodes JM; Zelenetz AD; Alencar A; Roeker LE; Mehta S; Garippa R; Linley A; Soni RK; Skånland SS; Brown RJ; Mato AR; Hansen GM; Abdel-Wahab O; Taylor J
Science; 2024 Feb; 383(6682):eadi5798. PubMed ID: 38301010
[TBL] [Abstract] [Full Text] [Related]
8. FPFT-2216, a Novel Anti-lymphoma Compound, Induces Simultaneous Degradation of ikzf1/3 and CK1α to Activate p53 and Inhibit NFκB Signaling.
Kanaoka D; Yamada M; Yokoyama H; Nishino S; Kunimura N; Satoyoshi H; Wakabayashi S; Urabe K; Ishii T; Nakanishi M
Cancer Res Commun; 2024 Feb; 4(2):312-327. PubMed ID: 38265263
[TBL] [Abstract] [Full Text] [Related]
9. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract] [Full Text] [Related]
10. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
Bastian L; Beder T; Barz MJ; Bendig S; Bartsch L; Walter W; Wolgast N; Brändl B; Rohrandt C; Hansen BT; Hartmann AM; Iben K; Das Gupta D; Denker M; Zimmermann J; Wittig M; Chitadze G; Neumann M; Schneller F; Fiedler W; Steffen B; Stelljes M; Faul C; Schwartz S; Müller FJ; Cario G; Harder L; Haferlach C; Pfeifer H; Gökbuget N; Brüggemann M; Baldus CD
Blood; 2024 Apr; 143(14):1391-1398. PubMed ID: 38153913
[TBL] [Abstract] [Full Text] [Related]
11. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
12. Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.
Foà R; Bassan R; Elia L; Piciocchi A; Soddu S; Messina M; Ferrara F; Lunghi M; Mulè A; Bonifacio M; Fracchiolla N; Salutari P; Fazi P; Guarini A; Rambaldi A; Chiaretti S
J Clin Oncol; 2024 Mar; 42(8):881-885. PubMed ID: 38127722
[No Abstract] [Full Text] [Related]
13. Design and Development of IKZF2 and CK1α Dual Degraders.
Miyamoto DK; Curnutt NM; Park SM; Stavropoulos A; Kharas MG; Woo CM
J Med Chem; 2023 Dec; 66(24):16953-16979. PubMed ID: 38085607
[TBL] [Abstract] [Full Text] [Related]
14. IKZF3 polymorphisms contribute to the increased risk of acute lymphoblastic leukemia in children.
Yang X; Yang L; Luo A; Liu S; Zhang X; Liu X; Liu X; Luo A; Cai M; Yan Y; Wu X; Huang K; Xu L; Jiang H
Cancer; 2024 Mar; 130(6):973-984. PubMed ID: 38018448
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory.
Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
[TBL] [Abstract] [Full Text] [Related]
16. Pre- and Postnatal Exposures to Tobacco Smoking and Survival of Childhood Acute Lymphoblastic and Myeloid Leukemias in California, United States.
Metayer C; Morimoto LM; Kang AY; Sanchez Alvarez J; Winestone LE
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):117-125. PubMed ID: 37921440
[TBL] [Abstract] [Full Text] [Related]
17. Toblerone: detecting exon deletion events in cancer using RNA-seq.
Lonsdale A; Halman A; Brown L; Kosasih H; Ekert P; Oshlack A
F1000Res; 2023; 12():130. PubMed ID: 37767021
[TBL] [Abstract] [Full Text] [Related]
18. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic Leukemia in the Kazakh Population.
Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
[TBL] [Abstract] [Full Text] [Related]
19. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
Kim R; Bergugnat H; Pastoret C; Pasquier F; Raffoux E; Larcher L; Passet M; Grardel N; Delabesse E; Kubetzko S; Caye-Eude A; Meyer C; Marschalek R; Lafage-Pochitaloff M; Thiebaut-Bertrand A; Balsat M; Escoffre-Barbe M; Blum S; Baumann M; Banos A; Straetmans N; Gallego-Hernanz MP; Chalandon Y; Graux C; Soulier J; Leguay T; Hunault M; Huguet F; Lhéritier V; Dombret H; Boissel N; Clappier E
Blood; 2023 Nov; 142(21):1806-1817. PubMed ID: 37595275
[TBL] [Abstract] [Full Text] [Related]
20.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract] [Full Text] [Related]
[Next]
